Minimally invasive surfactant therapy: An update

NeoReviews

Volumn 15, Issue 7, 2014, Pages

  Aguar, Marta ^a   Vento, Maximo ^a,b   Dargaville, Peter A ^c,d  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HEALTH RESEARCH INSTITUTE LA FE   (Spain)

^c UNIVERSITY OF TASMANIA   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903772342     PISSN: 15269906     EISSN: 15269906     Source Type: Journal    
DOI: 10.1542/neo.15-7-e275     Document Type: Article

References (44)

1. Vento M. Noninvasive respiratory support in the delivery room: introduction. Neoreviews. 2012;13(6):e334-e335
2. Jobe AH. Pharmacology review: why surfactant works for respiratory distress syndrome. Neoreviews. 2006;7(2):e95-e106
3. Speer CP, Sweet DG, Halliday HL. Surfactant therapy: past, present and future. Early Hum Dev. 2013;89(suppl 1):S22-S24
4. Vento M, Cheung PY, Aguar M. The first golden minutes of the extremely-low-gestational-age neonate: a gentle approach. Neo-natology. 2009;95(4):286-298
5. Guttentag S, Foster CD. Update in surfactant therapy. Neore-views. 2011;12(11):e625-e634
6. Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev. 2009; (2):CD007836
7. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB; COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008;358(7):700-708
8. Finer NN, Carlo WA, Walsh MC, et al; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362(21):1970-1979
9. Dunn MS, Kaempf J, de Klerk A, et al; Vermont Oxford Network DRM Study Group. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neo-nates. Pediatrics. 2011;128(5):e1069-e1076
10. Verder H, Robertson B, Greisen G, et al; Danish-Swedish Multicenter Study Group. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med. 1994;331(16):1051-1055
11. Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics. 1999;103(2):E24
12. Bohlin K, Henckel E, Blennow M. International perspectives: Surfactant without assisted ventilation: the Scandinavian perspective. Neoreviews. 2008;9(12):e555-e561
13. Suresh GK, Soll RF. Overview of surfactant replacement trials. JPerinatol. 2005;25(suppl 2):S40-S44
14. Escobedo MB, Gunkel JH, Kennedy KA, et al; Texas Neonatal Research Group. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. JPediatr. 2004;144(6):804-808
15. Reininger A, Khalak R, Kendig JW, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol. 2005;25(11):703-708
16. Sandri F, Plavka R, Ancora G, et al; CURPAP Study Group. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics. 2010;125(6):e1402-e1409
17. Klebermass-Schrehof K, Wald M, Schwindt J, et al. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Neonatology. 2013;103(4):252-258
18. Sweet DG, Carnielli V, Greisen G, et al; European Association of Perinatal Medicine. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2013 update. Neonatology. 2013;103(4):353-368
19. Schmölzer GM, Kumar M, Pichler G, Aziz K, O'Reilly M, Cheung PY. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis [published correction appears in BMJ. 2014;348:g58]. BMJ. 2013;347: f5980
20. Mehler K, Grimme J, Abele J, Huenseler C, Roth B, Kribs A. Outcome of extremely low gestational age newborns after introduction of a revised protocol to assist preterm infants in their transition to extrauterine life. Acta Paediatr. 2012;101(12):1232-1239
21. Herting E. Less invasive surfactant administration (LISA)- ways to deliver surfactant in spontaneously breathing infants. Early Hum Dev. 2013;89(11):875-880
22. Dargaville PA. Innovation in surfactant therapy I: surfactant lavage and surfactant administration by fluid bolus using minimally invasive techniques. Neonatology. 2012;101(4):326-336
23. Pillow JJ, Minocchieri S. Innovation in surfactant therapy II: surfactant administration by aerosolization. Neonatology. 2012;101 (4):337-344
24. Roehr CC, Morley CJ, Vento M. Improving neonatal transition by giving ventilatory support in the delivery room. Neoreviews. 2012;13(6):e343-e352
25. Kribs A, Pillekamp F, Hünseler C, Vierzig A, Roth B. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age
26. Kribs A, Vierzig A, Hünseler C, et al. Early surfactant in spontaneously breathing with nCPAP in ELBW infants-a single centre four year experience. Acta Paediatr. 2008;97(3):293-298
27. Kribs A, Härtel C, Kattner E, et al. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data. Klin Padiatr. 2010;222(1):13-17
28. Göpel W, Kribs A, Ziegler A, et al; German Neonatal Network. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378 (9803):1627-1634
29. Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed. 2011;96(4):F243-F248
30. Dargaville PA, Aiyappan A, De Paoli AG, et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed. 2013;98(2): F122-F126
31. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics. 2013;131(2):e502-e509
32. Aguar M, Cernada M, Brugada M, Gimeno A, Gutierrez A, Vento M. Instillation of surfactant by tracheal catheterization with an orogastric tube versus standard INSURE technique: a prospective observational study. Acta Paediatr. 2014; DOI 10.1111/apa.12611
33. Mazela J, Merritt TA, Finer NN. Aerosolized surfactants. Curr Opin Pediatr. 2007;19(2):155-162
34. Minocchieri S, Berry C, Pilow J Nebulized surfactant for treatment of respiratory distress in the first hours of life: the CureNeb Study (abstract). E-PAS2013:3500.7
35. Attridge JT, Stewart C, Stukenborg GJ, Kattwinkel J. Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial. Am J Perinatol. 2013;30(3):201-206
36. Abdel-Latif ME, Osborn DA. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2011;(7):CD008309
37. Niemarkt H, Elke K, Kribs A, Jellema R, Daan O, Nikforou M Oxygenation and pulmonary distribution of endotracheal bolus surfactant therapy in spontaneously breathing sheep (abstract). E-PAS 2013: 1550.688.
38. Bahadue FL, Soll R Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;(11):CD001456
39. Dargaville PA, Aiyappan A, De Paoli AG, et al. Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences. Neonatology. 2013;104(1):8-14
40. De Jaegere AP, van der Lee JH, Canté C, van Kaam AH. Early prediction of nasal continuous positive airway pressure failure in preterm infants less than 30 weeks gestation. Acta Paediatr. 2012; 101(4):374-379
41. Porath M, Korp L, Wendrich D, Dlugay V, Roth B, Kribs A. Surfactant in spontaneous breathing with nCPAP: neurodevelop-mental outcome at early school age of infants £ 27 weeks. Acta Paediatr. 2011;100(3):352-359
42. Konishi M, Fujiwara T, Naito T, et al. Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high- versus low-dose of surfactant TA. Eur J Pediatr. 1988;147(1):20-25
43. Halliday HL, Tarnow-Mordi WO, Corcoran JD, Patterson CC. Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial). Arch Dis Child. 1993;69(3 Spec No):276-280
44. Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K; North American Study Group. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol. 2004;21(3):109-119